Cargando…

CAR-T细胞桥接异基因造血干细胞移植治疗复发/难治急性B淋巴细胞白血病的临床分析

OBJECTIVE: This study aims to investigate the efficacy and safety of chimeric antigen receptor(CAR)T-cell bridging allogeneic hematopoietic stem cell transplantation(allo-HSCT)in the treatment of recurrent and refractory acute B-lymphocytic leukemia(R/R B-ALL). METHODS: A total of 50 R/R B-ALL patie...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595870/
https://www.ncbi.nlm.nih.gov/pubmed/33113601
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.09.002